29 phd-in-building-materials PhD positions at University of Cambridge in United-States
-
non-clinical PhD studentship in cardiometabolic research, commencing October 2026 in the Department of Medicine (VPD Heart & Lung Research Institute), University of Cambridge. The project will be based
-
mouse models and immunology expertise (CRUK-CI), access to relevant patient material (matched fresh-frozen PDAC and serum samples). We will utilize AstraZeneca expertise in spatial and circulatory
-
A position exists, for a Research Assistant/Associate in the Department of Engineering, to work on Novel Materials for Stratospheric Aerosol Injection (Delivery). The post holder will be located in
-
A position exists, for a Research Assistant/Associate in the Department of Engineering, to work on Novel Materials for Stratospheric Aerosol Injection (Dispersal). The post holder will be located in
-
Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country United Kingdom Application Deadline 15 Sep 2025 - 23:59 (Europe/London) Type of Contract Temporary Job Status Full-time Offer
-
Supervisors: Professor Greg Hannon and Dr Ben Nicholson For further information about the research group, including their most recent publications, please visit their websites: https://www.cruk.cam.ac.uk/research-groups/hannon-group and http://www.hannonlab.org/ Overview We are looking for a...
-
@ch.cam.ac.uk , including 'PhD CI ¿ October 2026' in the subject. How to apply Please apply via the University Applicant Portal. For further information about the course and to access the Applicant Portal, click
-
earlier as well as understand the mechanisms driving CIN. This project will aim to build upon previous work within the group developing computational methodologies to detect and deconvolute the mutational
-
Two fully-funded 3-year PhD studentships are available in Neuromorphic and Bio-inspired computing at the interface between control engineering, electrical engineering, computational neuroscience
-
Supervisors: Professor Sir Steve Jackson and Dr Mark O'Connor (AZ Partner) Course start date: 1st October 2026 Project details Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. ...